Evidence map›Paper›PMID 37715090›Full record

ArticleMolecular imaging and biology2023

Use of Magnetotactic Bacteria as an MRI Contrast Agent for In Vivo Tracking of Adoptively Transferred Immune Cells.

Andrea Nuschke, Caitrin Sobey-Skelton, Bassel Dawod, Brianna Kelly, Marie-Laurence Tremblay, Christa Davis, James A Rioux, Kimberly Brewer

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Andrea NuschkeBiomedical MRI Research Laboratory, IWK Health Centre, Halifax, NS, Canada.
Caitrin Sobey-SkeltonBiomedical MRI Research Laboratory, IWK Health Centre, Halifax, NS, Canada.
Bassel DawodBiomedical MRI Research Laboratory, IWK Health Centre, Halifax, NS, Canada.
Brianna KellyBiomedical MRI Research Laboratory, IWK Health Centre, Halifax, NS, Canada.
Marie-Laurence TremblayBiomedical MRI Research Laboratory, IWK Health Centre, Halifax, NS, Canada.
Christa DavisBiomedical MRI Research Laboratory, IWK Health Centre, Halifax, NS, Canada.
James A RiouxBiomedical MRI Research Laboratory, IWK Health Centre, Halifax, NS, Canada.
Kimberly BrewerBiomedical MRI Research Laboratory, IWK Health Centre, Halifax, NS, Canada. brewerk@dal.ca.ORCID 0000-0001-7973-0126
Dalhousie University · CAIzaak Walton Killam Health Centre · CA

Funding

IWK Health Centre Project GrantNatural Science and Engineering Council (NSERC) Discovery Grant
6 · The paper itself

Abstract

purposeIn vivo immune cell tracking using MRI can be a valuable tool for studying the mechanisms underlying successful cancer therapies. Current cell labeling methods using superparamagnetic iron oxide (SPIO) lack the persistence to track the fate and location of transplanted cells long-term. Magnetospirillum magneticum is a commercially available, iron-producing bacterium that can be taken up by and live harmoniously within mammalian cells as magneto-endosymbionts (MEs). MEs have shown promise as labeling agents for in vivo stem and cancer cell tracking but have yet to be evaluated in immune cells. This pilot study examined ME labeling in myeloid-derived suppressor cells (MDSCs), cytotoxic T lymphocytes (CTLs), and dendritic cells (DCs) and its effects on cell purity, function, and MRI contrast. PROCEDURES: MDSCs, CTLs, and DCs were incubated with MEs at various ME labeling ratios (MLR), and various biological metrics and iron uptake were assessed. For in vivo imaging, MDSCs were labeled overnight with either MEs or SPIO (Molday ION Rhodamine B) and injected into C3 tumor-bearing mice via tail vein injection 24 days post-implant and scanned daily with MRI for 1 week to assess cellular quantification.

resultsFollowing incubations, MDSCs contained > 0.6 pg Fe/cell. CTLs achieved Fe loading of < 0.5 pg/cell, and DCs achieved Fe loading of ~ 1.4 pg/cell. The suppressive functionality of MDSCs at 1000 MLR was not affected by ME labeling but was affected at 2000 MLR. Markers of CTL dysfunction were not markedly affected by ME labeling nor were DC markers. In vivo data demonstrated that the MDSCs labeled with MEs generated sufficient contrast to be detectable using TurboSPI, similar to SPIO-labeled cells.

conclusionsCells can be labeled with sufficient numbers of MEs to be detectable with MRI without compromising cell viability. Care must be taken at higher concentrations of MEs, which may affect some cell types' functional activity and/or morphology. Immune cells with minimal phagocytic behavior have much lower iron content per cell after incubation with MEs vs SPIO; however, MEs can successfully be used as a contrast agent for phagocytic immune cells.

Indexed as

Adoptive TransferCell TrackingContrast MediaMagnetic Resonance ImagingMagnetospirillumAnimalsDendritic CellsFemaleMiceMice, Inbred C57BLMyeloid-Derived Suppressor CellsT-Lymphocytes, CytotoxicContrast MediaCell trackingCytotoxic T lymphocytes (CTLs)Dendritic cells (DCs)Magnetic resonance imaging (MRI)Magneto-endosymbionts (MEs)Myeloid-derived suppressor cells (MDSCs)Myeloid lineage cells (MLCs)

Identifiers

PMID37715090
OpenAlexW4386768162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.